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Introduction: Classic studies of limb ischemia–reperfusion injury have been performed using young healthy mice.
However, patients with peripheral vascular disease are older and often exhibit metabolic derangements that may delay
healing after revascularization. Mice with genetic deletion of apolipoprotein E (ApoE–/–) have been used as a model in
various experimental scenarios of hypercholesterolemia. These experiments evaluated the inflammatory response and
changes in skeletal muscle morphology during the acute and chronic phases of limb ischemia–reperfusion injury in aged
ApoE–/– mice.
Methods: Age-matched ApoE–/– and wild-type (Wt) mice underwent 1.5 hours of unilateral hind limb ischemia, followed
by 1, 7, or 14 days of reperfusion (DR). Histologic analysis of skeletal muscle fiber injury was assessed at 1DR.
Morphologic evidence of muscular fiber maturation was assessed at 14DR. Levels of MyoD and myogenin, markers of
skeletal muscle differentiation, were assessed at 7 and 14DR using Western blots. Markers of inflammation, including
myeloperoxidase, macrophage inflammatory protein-2 (MIP-2), monocyte chemotactic protein-1 (MCP-1), and os-
teopontin, were assayed using enzyme-linked immunosorbent assay and chemokine (C-C motif) receptor 2 (CCR2) using
Western blots at 1, 7, and 14DR. After 1DR, tissue adenosine 5=-triphosphate (ATP) levels were measured to assess
metabolic activity. Unpaired t test and Mann-Whitney test were used for comparisons.
Results: Histologic evaluation of skeletal muscle after 1DR showed no difference in the degree of injury between Wt and
ApoE–/– mice. However, at 14DR, ApoE–/– mice had higher percentage of immature muscle fibers than Wt mice.
Myogenin level was lower in the ApoE–/– mice at 7DR. Injured skeletal muscle of ApoE–/– mice had lower levels of
myeloperoxidase than Wt mice at 7 DR and higher levels of MCP-1 at 14DR. There was no difference in the levels of tissue
ATP, MIP-2, osteopontin, or CCR2 at all experimental intervals.
Conclusion: Although there was no difference between the injured muscle of Wt and ApoE–/– mice during the acute phase
of reperfusion, ApoE–/– mice showed delay in skeletal muscle healing during the chronic phase of reperfusion. This lag
in muscle regeneration was associated with lower levels of myogenin at 7DR and an increased level of MCP-1 at 14DR in
the ApoE–/– mice. The delay in skeletal muscle healing in the ApoE–/– mice may have broader implications for poor tissue
healing and functional recovery in elderly patients who have vascular risk factors such as hypercholesterolemia. (J Vasc
Surg 2008;48:701-8.)
Clinical Relevance: These studies demonstrate that hypercholesterolemia, a major risk factor for peripheral arterial
disease, does not alter the acute consequences of skeletal muscle ischemia–reperfusion injury. Hypercholesterolemia did
significantly compromise skeletal muscle healing during the chronic phase of reperfusion in these mice, which is
temporally coincident with wound complications and poor functional recovery in humans.Peripheral arterial disease (PAD) is estimated to affect any-
where from 3% to 30% of the adult population in the United
States.1-5 Major risk factors for PAD include age, hypertension,
hypercholesterolemia, diabetes mellitus, chronic renal insuffi-
ciency, and smoking. Often, an acute thrombotic or embolic
event may prompt hypercholesterolemic patients to seek
help in managing their lower extremity vascular disease.
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doi:10.1016/j.jvs.2008.04.006Among patients with established symptomatic PAD, about
5% to 10% undergo revascularization within 5 years, and
about 1% to 5% require an amputation.6,7 After revascular-
ization, the risk of failure of graft patency, wound healing,
and return to baseline functional status is significantly in-
fluenced by the patient’s comorbidities.8 A number of
studies have reported hypercholesterolemia as an indepen-
dent predictor of poor outcome after a patient undergoes
revascularization for PAD.9-11
Apolipoprotein E (ApoE) is a glycoprotein synthesized by
the liver and macrophages and is a constituent of plasma lipopro-
teins.12,13 It serves as a ligand for the cell-surface lipoprotein
receptors and therefore is important in clearing lipoprotein rem-
nants from the circulation. It is also a strong acceptor of
cellular cholesterol and is thought to play an important role
in preventing foam cell formation in the vessel wall.14,15
Genetic deletion of ApoE (ApoE–/–) in mice results in
profoundly hypercholesterolemic animals whose choles-
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(Wt) control strains, C57BL/6, have cholesterol levels of
60 to 90 mg/dL.13,15 As such, ApoE–/– mice have been
used extensively to study the effects of hypercholesterol-
emia in various disease processes such as atherosclerosis and
stroke.
The following studies were designed to study the
effects of hypercholesterolemia after acute hind limb
ischemia–reperfusion injury in aged ApoE–/– mice and
age-matched C57BL/6 mice as controls. The local met-
abolic and inflammatory markers, indices of skeletal muscle
differentiation, and muscle morphology were compared
during the acute and chronic phases of reperfusion.
METHODS
Animal protocol and limb ischemia reperfusion.
These experiments used 8- to 10-month-old, female
ApoE–/– and their control strain, C57BL/6 mice (Jackson
Laboratory, Bar Harbor, Me). Animal care and experimen-
tal procedures were performed in accordance with the
“Principles of Laboratory Animal Care,” Guide for the Care
and Use of Laboratory Animals (National Institutes of
Health Publication No. 86-23, revised 1996) and approved
by the Massachusetts General Hospital’s Subcommittee on
Research Animal Care.
Anesthesia was induced by intraperitoneal injection of
sodium pentobarbital (50 mg/kg), and maintained by ad-
ministering a subsequent dose of 10 mg/kg as needed.
After induction of anesthesia, unilateral hind limb ischemia
was achieved by applying 4.5-oz orthodontic rubber bands
(American Orthodontics, Sheboygan, Wis) on the hind
limbs using the McGivney Hemorrhoidal Ligator Applica-
tor (George Percy McGown, Brooklyn, NY) as previously
described.16 Orthodontic rubber bands were then removed
after 90 minutes of ischemia. Mice were placed on a heating
pad during the ischemic and immediate recovery period to
maintain normal body temperature of 37°C.
Once the mice were awakened from anesthesia, they
were returned to their cages and allowed free access to
water and food. After reperfusion periods of 1, 7, or 14
days, mice were euthanized with intraperitoneal injection
of sodium pentobarbital (200 mg/kg). Blood and skeletal
muscle from the ischemic and contralateral hind limbs were
then harvested from each mouse. For histologic studies,
limbs were fixed in 4% paraformaldehyde. For biochemical
assays, posterior compartments of calf skeletal muscles from
each mouse were dissected out, snap frozen in liquid nitro-
gen, and stored at –80°C until extraction.
Serum cholesterol levels. Serum cholesterol levels of
Wt and ApoE–/– sham mice were measured to verify their
cholesterol profile. Whole blood was collected from Wt and
ApoE–/– sham mice. Blood samples were allowed to clot at
room temperature for approximately 60 minutes and then
centrifuged at 3000g for 20 minutes. The resulting super-
natant was stored at –80°C until analysis. Serum choles-
terol levels for Wt and ApoE–/– mice were measured using
Infinity Cholesterol Kit (Thermo Electron Corporation,
Louisville, Colo) according to the manufacturer’s protocol.Histology. Limbs from mice that underwent hind
limb ischemia and reperfusion were fixed in 4% paraformal-
dehyde for 8 hours. The gastrocnemius muscle from each
limb was dissected out, rinsed in Dulbecco Phosphate
Buffered Saline (PBS) for 1 hour, and serially dehydrated in
graded acetone. Each sample was embedded using JB-4
Embedding Kit (Polysciences Inc, Warrington, Pa) under
vacuum conditions, cut in cross-section at 2-m thickness
using a motorized microtome (Leica Microsystems Inc,
Bannockburn, Ill), and stained with Masson trichrome for
1 day reperfusion samples and hematoxylin and eosin for 14
day reperfusion samples.
Stained slides were examined under light microscopy at
200 magnification (Nikon E600 Upright Microscope,
Tokyo, Japan). Images were acquired from the entire mus-
cle section, and each image was assigned a serial number
using SPOT Insight Digital Camera (Diagnostic Instru-
ments, Sterling Heights, MI). The blinded observer then
examined the images of each muscle in random order using
a random number generator (www.randomizer.org) until a
minimum of 1200 muscle fibers per section had been
scored.
For limbs that under went 1 day of reperfusion (DR),
muscle fibers were scored as uninjured or injured based on
the morphology of the individual fibers. Uninjured fibers
were characterized as having well-defined borders, uniform
texture and colors, and easily identifiable satellite cells and
pericellular nuclei.17 Injured fibers, on the other hand, had
interrupted or ragged borders, inconsistent texture and
color, breaks in the cytoplasm, and nuclei detachment.
Histologic assessment of muscle fibers at 14DR was based
on the presence of mature skeletal muscle fibers (small
peripheral nuclei) vs immature proliferative skeletal muscle
myoblasts (large lobulated central nuclei).18 For 1DR sam-
ples, scores were summarized as percentage of injured
fibers, whereas for 14DR samples, scores were summarized
as percentage of immature fibers.
Tissue MyoD, myogenin, and chemokine (C-C mo-
tif) receptor 2 (CCR2) levels. Total protein (40 g) was
solubilized with an equal volume of Laemmli sample buffer
(0.25M Tris-HCl, pH 6.8; 8% sodium dodecyl sulfate, 40%
glycerol, 0.4M dithiothreitol, and 0.04% Bromophenol
Blue; BioRad, Hercules, Calif), boiled for 5 minutes, and
loaded onto a 12% density Tris-HCl polyacrylamide-sodium
dodecyl sulfate gel. Samples underwent electrophoresis, fol-
lowed by electroblotting transfer to a nitrocellulose mem-
brane (BioRad). The membranes were blocked in PBS con-
taining 0.05% Tween-20 (PBS-T) supplemented with 5%
nonfat dried milk for 1 hour at room temperature. The
blots were then incubated with rabbit polyclonal anti-
MyoD antibody, rabbit polyclonal antimyogenin antibody,
or goat polyclonal anti-CCR2 antibody (Santa Cruz Bio-
technology, Santa Cruz, Calif) in blocking buffer at opti-
mum dilution of 1:1000 for 1 hour.
After washes in PBS-T, the membranes were probed
with horseradish peroxide-conjugated goat antirabbit im-
munoglobulin G (IgG) at 1:4000 dilutions in blocking
buffer for 1 hour at room temperature. Membranes were
JOURNAL OF VASCULAR SURGERY
Volume 48, Number 3 Kang et al 703washed with PBS-T and developed using the enhanced
chemiluminescence Western Blot Detection Reagent (GE
Healthcare, Piscataway, NJ) at 1:20 dilution. Chemilumi-
nescence light was visualized by exposing the blots onto a
Kodak BioMAX x-ray film (Sigma-Aldrich, St Louis, Mo).
Band densities of the specific proteins were measured using
a gel imaging system (Alpha Innotech Corp, San Leandro,
Calif). Blots were then stripped, reprobed using rabbit
antimouse -tubulin IgG (Abcam, Cambridge, Mass), and
incubated with polyclonal goat anti-rabbit IgG. Band den-
sities were then estimated using the same protocol as above.
Expression of MyoD, myogenin, and CCR2 were reported
relative to -tubulin.
Tissue myeloperoxidase (MPO), macrophage in-
flammatory protein-2 (MIP-2), monocyte chemotactic
protein-1 (MCP-1), and osteopontin levels. Frozen
muscle (200 mg) samples were homogenized with a poly-
tron homogenizer in a test tube containing 1 mL of Radio-
immunoassay Precipitation Assay (RIPA) Buffer and 10 L
of protease inhibitor cocktail (Sigma P-8340, St Louis,
Mo). The homogenized samples were then centrifuged at
16,000g for 10 minutes, and the supernatants were frozen
in aliquots at –80°C until analysis.
The hind limb skeletal muscle levels of MPO, MIP-2,
MCP-1, and osteopontin were measured using commercially
available enzyme-linked immunosorbent assay (ELISA) kits
according to the manufacturer’s protocols (MPO, Cell Sci-
ences, Canton, MA; MIP-2, MCP-1, osteopontin: R&D Sys-
tems, Minneapolis, Minn). The ELISA plates were read with a
Spectromax-250 plate reader (Molecular Devices, Sunny-
vale, Calif). Total protein concentration in each skeletal
muscle extract was determined using the BCA Protein
Assay Reagent Kit (Pierce Biotechnology, Rockford, Ill)
with bovine serum albumin as the standard. MPO, MIP-2,
MCP-1 and osteopontin concentrations were extrapolated
off the standard curve and normalized to the total protein
concentration.
Tissue adenosine 5=-triphosphate (ATP) levels.
Samples of frozen muscle (200 mg) were homogenized
with a polytron homogenizer in a test tube containing 10%
trichloroacetic acid. Samples were centrifuged for 10 min-
utes at 10,000g, and supernatants were diluted in PBS. The
ATP levels were measured using ATPlite Luminescence Assay
according to the manufacturer’s protocol (PerkinElmer
Life, Boston, Mass). Top counts were read using 1450
MicroBeta plate reader (PerkinElmer Life) Concentrations
of the unknowns were extrapolated off the standard curve
and expressed as nanomole per mg tissue weight. The ATP
levels of the reperfused limbs were then divided by ATP
levels of the respective contralateral limbs and expressed as
percentage of contralateral limb ATP level.
Statistical analysis. All data were expressed as mean
standard error of the mean and all analyses were performed
using InStat 3 (GraphPad Software, San Diego, Calif).
Comparisons between the ApoE–/– and Wt groups were
made using the unpaired t test or Mann-Whitney test.RESULTS
Serum cholesterol Levels. Serum cholesterol levels
were measured in Wt and ApoE–/– mice. ApoE–/– mice had
significantly higher levels of serum cholesterol compared
with Wt mice (104  3 vs 491  12 mg/dL; P  .0001).
Histology. Histologic assessment of Wt and ApoE–/–
gastrocnemius muscles was done at 1DR and 14DR to
study the effects of transient ischemia during the acute and
chronic phases of reperfusion. At 1DR, both Wt and
ApoE–/– mice demonstrated a significant amount of muscle
fiber injury, interstitial edema, and infiltrating leukocytes in
the skeletal muscle. Representative images from both Wt
and ApoE–/– gastrocnemius muscles are shown in Fig 1, a
and b, respectively. Quantitative assessment of skeletal mus-
cle revealed no difference in the level of injury between Wt
and ApoE–/– mice at 1 day after reperfusion (Wt 48% 6%
injured fibers vs ApoE–/– 42%  5% injured fibers; P 
.444; Fig 2, a).
After 2 weeks of reperfusion, both Wt and ApoE–/–
mice had evidence of skeletal muscle regeneration as indi-
cated by the presence of immature fibers with centrally
located nuclei. Representative images from Wt and
ApoE–/– gastrocnemius muscles are shown in Fig 1, c and
d, respectively. Unlike the acute phase of reperfusion, at
14DR, there was a significant difference in skeletal muscle
morphology between Wt and ApoE–/– mice (Fig 2, b). Wt
mice had 47%  5% immature fibers, whereas ApoE–/–
mice had 68%  5% immature fibers (P  .007).
Tissue MyoD and myogenin levels. Quantitative val-
ues of band densities for MyoD and myogenin are shown in
Fig 3, a and b, respectively. Although no difference was
noted in the level of MyoD between Wt and ApoE–/– at
either time points, the level of myogenin in ApoE–/– mice
was significantly lower at 7DR (Wt 13.9  1.7 AU vs
ApoE–/– 7.7  1.2 AU; P  .014). By 14DR, the differ-
ence in myogenin levels between Wt and ApoE–/– mice was
not significant (Wt 6.8  1.3 AU vs ApoE–/– 4.9  0.9
AU; P  .299).
Tissue CCR2 levels. Quantitative values of band den-
sities for CCR2 were evaluated at 1DR, 7DR, and 14 DR in
Wt vs ApoE–/– mice. There was a significant increase in the
level of CCR 2 at 1DR compared with sham mice in both
groups. However, there was no difference in the levels
between the Wt and APO 2–/– groups, respectively, at any
time points: 1DR, 450.4 30.2 vs 436.5 25.9 AU (P
0.733); 7DR, 74.6 16.7 vs 79.7 11.4 AU (P .811);
and 14DR, 79.1  52.68 vs 46.6  20.5 AU (P  .999).
Tissue MPO, MIP-2, MCP-1, and osteopontin
levels. MPO levels in the ischemic limbs of Wt and
ApoE–/– mice were measured to assess the degree of neu-
trophil activation. MPO levels in both Wt and ApoE–/–
mice were significantly elevated at 1 day after reperfusion
compared with baseline MPO levels (Fig 4, a). There was
no difference in the tissue MPO levels between Wt and
ApoE–/– mice at 1DR (155.8  17.8 vs 185.8  14.1
ng/mg; P  .204). By day 7 of reperfusion, the MPO
level in ApoE–/– mice was slightly lower than Wt mice (Wt,
e cen
or of
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.043), but by 14DR, there was no difference in MPO levels
between the two groups (Wt, 6.0  1.8 ng/mg vs
Fig 1. Skeletal muscle morphology. (a and b) Masson
original magnification200 magnification (Bar, 100 m
day of reperfusion (DR). b, Gastrocnemius muscle from
is no difference in the level of initial injury between Wt an
polygonal shape (circle), interstitial edema, and infiltratin
mice after 14DR. d, Gastrocnemius muscle from ApoE–
in skeletal muscle morphology between Wt and Apo
characteristic polygonal shape, larger cross-sectional siz
mice have many immature fibers that are smaller and hav
Fig 2. Skeletal muscle fiber counts. a, There was no d
C57BL/6) and apolipoprotein E deficient (ApoE–/–) mic
of immature skeletal muscle fibers in ApoE–/– mice at 14D
fibers; *P  .444). Error bars represent the standard errApoE–/–, 8.3  3.2 ng/mg; P  .879).Tissue MIP-2 levels were assessed as a measure of
neutrophil chemotactic activity in the hind limbs of Wt and
ApoE–/– mice after ischemia reperfusion injury. MIP-2
chrome and (c and d) hematoxylin and eosin stains at
Gastrocnemius muscle from wild-type (Wt) mice after 1
poprotein E deficient (ApoE–/–) mice after 1DR. There
E–/– mice. Both have rounded fibers that have lost their
ocytes (short arrows). c, Gastrocnemius muscle from Wt
e after 14DR. At 14DR, there is a significant difference
mice. Most Wt muscle fibers are mature with their
peripherally placed nuclei (long arrow). The ApoE–/–
trally placed nuclei (oval).
ce in percent of injured fibers between wild-type (Wt;
day of reperfusion (DR). b, There was a higher number
t 48% 6% injured fibers vs ApoE–/– 42% 5% injured
the mean.’s tri
). a,
apoli
d Apo
g leuk
/– mic
E–/–
e, andifferen
e at 1
R (Wlevels in both Wt and ApoE–/– mice were elevated at 1 day
he sta
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difference in MIP-2 levels between Wt and ApoE–/– mice
at 1DR (5.8 1.0 vs 5.8 1.0 pg/mg; P .982). By day
7 and 14 of reperfusion, MIP-2 levels were significantly
decreased in both groups, and there was no difference
between the Wt and ApoE–/– mice at either time points,
respectively: 7DR, 1.5  0.5 vs 1.2  0.5 pg/mg (P 
.397); and 14DR, 0.6  0.3 vs 1.0  0.1 pg/mg (P 
.127).
Tissue MCP-1 levels were measured as an index of
monocyte/macrophage chemotactic activity in the injured
skeletal muscles. There was no difference in MCP-1 levels
between Wt and ApoE–/– mice at 1 and 7DR (Fig 4, c).
However, at 14DR, MCP-1 was significantly higher in the
ApoE–/– mice (15.7  1.7 vs 38.5  3.9 pg/mg; P 
.0001).
Because osteopontin is an important glycophospho-
protein known to modulate immune response and muscle
remodeling, tissue osteopontin levels were assessed at 1DR,
7DR, and 14DR. A transient increase in osteopontin levels
occurred during early reperfusion, but there was no overall
difference between the two strains at any time point during
reperfusion (Fig 4, d).
Tissue ATP levels. ATP levels were measured at 1DR
to assess the level of metabolic activity in the skeletal
muscles of Wt and ApoE–/– mice after hind limb ischemia–
reperfusion injury. There was no difference in skeletal mus-
cle ATP levels between Wt and ApoE–/– mice (34% 8% vs
17%  5%; P  .099).
DISCUSSION
Our study shows that although there was no difference
in the level of injury between Wt and ApoE–/– mice during
the acute phase of reperfusion (Fig 2, a), there was delayed
Fig 3. Quantitative analysis of Western blots: MyoD an
of reperfusion (DR) in wild-type (Wt; C57BL/6) and ap
units (AU). a, There was no difference in MyoD levels
lower in the ApoE–/– mice at 7DR (Wt, 13.9 1.7 AU v
in myogenin expression at 14DR. Error bars represent thealing in the injured limbs of ApoE–/– mice during thechronic phase of reperfusion (Fig 2, b). This lag in skeletal
muscle regeneration was reflected in the lower levels of
myogenin in ApoE–/– mice at 7DR (Fig 3, b). Myogenin is
a marker of terminal differentiation in skeletal muscle.19
The relative decrease in myogenin expression at 7DR pre-
ceded the histologic appearance of immature skeletal mus-
cle fibers in ApoE–/– mice at 14DR (Fig 1, d).
In addition to the differences observed in myogenin
expression and skeletal muscle morphology, reperfused
limbs of ApoE–/– mice showed significantly higher level of
MCP-1 compared with Wt at 14DR (Fig 4, c), but showed
no difference in CCR2 levels at any time points. MCP-1, a
member of the CC chemokine family, is a potent recruiter of
circulating monocytes and certain subsets of T cells. Its activity
is mediated by its receptor, CCR2, a seven-transmembrane-
spanning G protein-coupled receptor.20 MCP-1 is thought to
play a key role in recruiting monocytes into early athero-
sclerotic lesions, in development of intimal hyperplasia after
angioplasty, and in arteriogenesis.21 In addition, MCP-1
has been shown to be important in skeletal muscle regen-
eration after injury.22-25
The higher levels of MCP-1 at 14DR after ischemic
injury may indicate a prolonged local inflammatory process
is associated with the delay in skeletal muscle regeneration
in the ApoE–/– mice. Because this higher level of MCP-1 is
not associated with difference in the level of CCR2 expres-
sion, it is also possible that the relatively higher levels of
MCP-1 observed in the ApoE–/– mice may be related to
decreased function of CCR2 in the ApoE–/– mice.
Evidence to support this possibility comes from the
work of Warren et al,23 who showed that mice treated with
MCP-1 antibodies, as well as mice deficient in CCR2
(CCR2–/–), had delayed skeletal muscle recovery after
freeze-induced injury. Furthermore, in the Warren study,
ogenin from reperfused skeletal muscle at 7 and 14 days
rotein E deficient (ApoE–/–) mice expressed in arbitrary
R or 14DR. b, Myogenin expression was significantly
E–/– 7.7 1.2 AU; *P .014). There was no difference
ndard error of the mean.d my
olipop
at 7D
s Apothe delay in skeletal muscle recovery was accompanied by a
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muscle of CCR2–/– mice at 14 days after injury, as evi-
denced by extensive immunostaining with Mac-1 and
Mac-3, markers of monocytes/macrophages.24 Interest-
ingly, they did not observe any difference in MyoD or
myogenin expression between CCR2–/– and Wt mice.
Their failure to observe differences in MyoD or myogenin
expression may be related to the nature of freeze-induced
injury, rather than warm ischemia reperfusion.
Because recent evidence from both clinical and experi-
mental studies demonstrates that inflammation plays a crit-
ical role in a wide variety of cardiovascular and vascular
diseases,21,26-35 we performed an intensive evaluation of
markers of inflammation and acute tissue injury after skel-
Fig 4. Skeletal muscle myeloperoxidase (MPO), macrop
tic protein-1 (MCP-1), and osteopontin (OPN) levels in s
(ApoE–/–) mice and in mice after unilateral hind limb isc
Tissue MPO levels were significantly lower in the ApoE–
ng/mg; *P .043). There was no difference at 1 or 14D
Wt and ApoE–/– mice at 1, 7, or 14DR. There was a s
ApoE–/– sham mice (Wt 0.11 0.03 pg/mg vs ApoE–/–
difference in tissue MCP-1 levels at 14DR (Wt 15.7 1.7
was no difference at 1 or 7DR. d, There was no differenc
the standard error of the mean.etal muscle reperfusion in Wt and ApoE–/– mice. Severalstudies of skeletal muscle ischemia–reperfusion injury indi-
cate a temporal and quantitative relationship between isch-
emia, reperfusion, tissue injury, and levels of proinflamma-
tory markers and cytokines.36-38 For these reasons, an
analysis of tissue levels of MPO, MIP-2, MCP-1, and
osteopontin were undertaken.
Under baseline, preischemic conditions, ApoE–/– mice
exhibited greater MIP-2 levels than the Wt controls. How-
ever, these levels were of questionable biologic significance
because they were measured at the lower end of the stan-
dard curve. MPO, MCP-1, and osteopontin levels were not
different between these strains at baseline conditions. This
observation is relevant primarily because these were aged
mice (8 to 10 months old), where the chronic exposure to
inflammatory protein-2 (MIP-2), monocyte chemotac-
wild-type (Wt;C57BL/6) and apolipoprotein E deficient
ia, followed by 1, 7, or 14 days of reperfusion (DR). a,
ce at 7DR (Wt 8.1  0.7 ng/mg vs ApoE–/– 5.3  0.9
, There was no difference in tissue MIP-2 levels between
cant difference in tissue MIP-2 levels between Wt and
 0.02 pg/mg; **P .040). c, There was a significant
mg vs ApoE–/– 38.5 3.9 pg/mg; P .0001). There
issue OPN levels at any time points. Error bars representhage
ham
hem
/– mi
R. b
ignifi
0.20
pg/
e in thypercholesterolemia in ApoE–/– mice could have influ-
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MPO levels were significantly greater than sham at
1DR for both Wt and ApoE–/– mice. By 7DR, there was
slightly lower level of MPO in the ApoE–/– vs Wt mice, but
this difference did not persist at 14DR. The biologic signifi-
cance of the differences in MPO at 7DR is not certain because
the levels were similar to baseline levels in the nonischemic,
non-reperfused muscle. Throughout the reperfusion intervals
that were analyzed, there were no significant differences in
either MIP-2 or osteopontin levels.
Ischemia–reperfusion is a complex process that involves
inflammatory and metabolic derangements as components
of tissue injury. To evaluate the metabolic consequences of
ischemia–reperfusion injury in these experiments, level of
ATP at 1DR was compared between Wt and ApoE–/– mice.
These levels were equally decreased at 1DR. Thus, it is
unlikely that metabolic differences between Wt and
ApoE–/– mice contributed to the process of delayed muscle
regeneration in these experiments.
CONCLUSIONS
These experiments reveal evidence of delayed skeletal
muscle regeneration in ApoE–/– mice after hind limb
ischemia–reperfusion. Age-matched controls did not ex-
hibit a similar pattern of delayed muscle healing. Delayed
skeletal muscle regeneration may contribute in part to
delayed functional recovery after lower extremity revascu-
larization. Although our analysis of tissue inflammation and
metabolism was not all-inclusive, it is unlikely that the delay
in skeletal muscle healing is caused by differences in the
degree of acute injury or inflammation. Rather, our data
show that persistent inflammation is present during the
chronic phase of reperfusion in the ApoE–/– mice. Further
studies evaluating the relationship between this delay in
skeletal muscle healing and the role of hypercholester-
olemic phenotype and how hypercholesterolemia may
modulate inflammatory response is warranted.
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